Boehringer Ingelheim finds Country MD for India in Vani Manja

Published On 2021-01-12 06:00 GMT   |   Update On 2021-01-12 08:18 GMT

New Delhi: Drug firm Boehringer Ingelheim on Monday said it has appointed Vani Manja as country Managing Director for India, effective January 1, 2021.In the role, Vani will assume responsibility for the company''s businesses in India, Bangladesh, Nepal and Sri Lanka. She will also join the board of the company, Boehringer Ingelheim said in a statement.Vani succeeds Sharad Tyagi, who retired...

Login or Register to read the full article

New Delhi: Drug firm Boehringer Ingelheim on Monday said it has appointed Vani Manja as country Managing Director for India, effective January 1, 2021.

In the role, Vani will assume responsibility for the company''s businesses in India, Bangladesh, Nepal and Sri Lanka. She will also join the board of the company, Boehringer Ingelheim said in a statement.

Vani succeeds Sharad Tyagi, who retired from Boehringer Ingelheim India on December 31, 2020, it added.

"India presents a unique opportunity for Boehringer Ingelheim, wherein we affirm our commitment to patients and people in the country with our products and services," Boehringer Ingelheim Head of Emerging Markets Thorsten Poehl said.

Vani is a proven and respected leader who has a strong track record of leading complex transformations and delivering results, he added.

She was formerly the Global Head of Boehringer Ingelheim''s Go-To-Market and Business Steering organisation, based in the company''s headquarters in Germany.

Read also: Scopus BioPharma appoints five new additional Directors

She joined Boehringer Ingelheim in the US in 2011, working across strategy and operations, marketing and sales leadership roles before moving to Ingelheim in 2016 as Regional Business Manager for Japan, the statement said.

She holds an MBA and MA in International Studies from the Wharton School at the University of Pennsylvania in Philadelphia, and a Bachelor''s degree with Honors in Chemistry from Delhi University, it added.

Read also: Aditya Puri appointed as Director of Stelis Biopharma, Advisor to Strides Group



Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News